FIRST ANNOUNCEMENT

KONGRES NASIONAL XVIII

Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia
(PAPDI)
“The Role of Internist in Global Health Improvement
in Artificial Intelligence and Big Data Era”
ORGANIZATIONAL MEETING | WORKSHOP | SYMPOSIUM
CONVOCATION | SCIENTIFIC COMPETITION

th th
July 13 - 17 , 2022 | HYBRID

Venue: VISIT US :
PO Hotel www.kopapdismg22.com
www.papdi.or.id
Patra Semarang Hotel & Convention
SEMARANG FOLLOW US ON:

CONTACT: kopapdisemarang
PAPDI SEMARANG CHAPTER kopapdisemarang
Joanna: 0822 3501 6950
KOPAPDI SEMARANG
Nindy: 0858 8502 5739
kopapdi semarang
KOPAPDI SEMARANG 2022
 WELCOMING SPEECH

Our challenge as an Internist in the future is both heavy and complex. The development of science
and technology brings us to artificial intelligence that could replace the role of doctor.

As an Internist, we have to face that problem and use artificial intelligence as technology to serve
better health care, more precision, more qualified toward precision medicine.

Excecutive board of Congress Indonesian Society of Internal Medicine held 18 National Congress
th

2022 in Semarang with general theme The Role of Internist in Global Health Improvement in Artificial
Intelligence and Big Data era for the preparation in facing challenges in the future. This congress will be held
in Hybrid Format because of pandemic COVID-19 that is not yet over and to make sure health protocol
management.

As the delegation of committee of 18 National Congress Indonesian Society of Internal Medicine in

th

Semarang, 2022, we hereby invite all colleagues to participate in the congress that will be held on July of 13
th

until 17th 2022 in Semarang. Semarang is a beautiful city that has many tourism object and capital of Central
Java Province. Semarang also offers so many entertainment and shopping center, various and delicious
culinary. See you later, online and also at Semarang!

Dr. dr. Sally Aman Nasution, SpPD, K-KV, FINASIM, FACP Dr. dr. Hery Djagat Purnomo, SpPD, K-GEH, FINASIM
Chairman of PB PAPDI Chairman of Committee KOPAPDI 2022

1
 COMMITTEE

PROTECTOR : Governor of Central Java Province

Chairman of PB IDI
ADVISOR : Chairman of PB PAPDI
Rector of Diponegoro University
Director of RSUP Dr. Kariadi
Chairman of IDI Semarang
Chairman of PAPDI Semarang
Prof. Dr. dr. Darmono, SpPD, K-EMD, FINASIM
Prof. Dr. dr. Sugiri, SpPD, SpJP(K), FINASIM, FIHA
Prof. Dr. Catharina Suharti, PhD, SpPD, K-HOM, FINASIM
Prof. Dr. dr. Soeharyo Hadisaputro, SpPD, K-PTI, FINASIM
Prof. dr. Muhammad Hussein Gasem, PhD, SpPD, K-PTI, FINASIM
Dr. dr. Lestariningsih, SpPD, K-GH, FINASIM
dr. Budi Riyanto, DTMH, MSc, SpPD, K-PTI, FINASIM
dr. Tony Suhartono, SpPD, K-EMD, FINASIM

CHAIRMAN OF COMMITTEE : Dr. dr. Hery Djagat Purnomo, SpPD, K-GEH, FINASIM
HEAD OF DIVISION I : Dr. dr. Tjokorda Gde Dalem Pemayun, SpPD, K-EMD, FINASIM
HEAD OF DIVISION II : dr. Eko Adhi Pangarsa, SpPD, K-HOM, FINASIM
HEAD OF DIVISION III : Dr. dr. Damai Santosa, SpPD, K-HOM, FINASIM

SECRETARY : dr. Budi Setiawan, SpPD, K-HOM, FINASIM

dr. Retty Kharisma Sari, SpPD

TREASURER : Dr. dr. Dwi Lestari Partiningrum, MSi.Med, SpPD, K-GH, FINASIM
dr. Rakhma Yanti Hellmi, SpPD, K-R, FINASIM
dr. Yohana Prima Ceria Anindita, SpPD

LIAISON OFFICER : Dr. dr. Eka Ginanjar, SpPD, K-KV, FINASIM, FACP, FICA, MARS

2
 COMMITTEE
DIVISION I DIVISION II

ORGANIZATION MEETING FUND RESOURCES

Dr. dr. Sukamto Koesnoe, SpPD, K-AI, FINASIM Dr. Med. Benny Santosa, SpPD, K-EMD, FINASIM
dr. Muhadi, SpPD, K-KV, FINASIM, M.Epid dr. Didi Kurniadhi, SpPD, K-KV, FINASIM
dr. Didik Indiarso, SpPD, K-GEH, FINASIM Prof. Dr. dr. Darmono, SpPD, K-EMD, FINASIM
dr. Zairullah Migfaza, SpPD dr. Kris Pranarka, SpF, SpPD, K-Ger, FINASIM
dr. F. Soemanto Padmomartono, MSc, SpPD, K-GEH, FINASIM
SCIENTIFIC dr. Suyatmi Awizar, SpPD, K-GEH, FINASIM
Dr. dr. Rudy Hidayat, SpPD, K-R, FINASIM Dr. dr. Suyanto Hadi, SpPD, K-R
dr. Simon Salim, SpPD, K-KV, FINASIM, M.Kes, FACP, AiFO dr. Muh. A. Sungkar, SpPD, K-KV, FINASIM, SpJP
dr. Ni Made Hustrini, SpPD, K-GH Dr. dr. Lestariningsih, SpPD, K-GH, FINASIM
Prof. Dr. dr. Sugiri, SpPD, SpJP(K), FINASIM. FIHA dr. Mika Lumban Tobing, SpPD, K-HOM, FINASIM
Prof. Dr. dr. Soeharyo Hadisaputro, SpPD, K-PTI, FINASIM Dr. dr. Hery Djagat Purnomo, SpPD, K-GEH, FINASIM
Prof. dr. Catharina Suharti, PhD, SpPD, K-HOM, FINASIM dr. Banteng Hanang Wibisono, SpPD, K-P, FINASIM
Prof. dr. Muhammad Hussein Gasem, PhD, SpPD, K-PTI, FINASIM Dr. dr. Shofa Chasani, SpPD, K-GH, FINASIM
dr. Murni Indrasti, SpPD, K-GH, FINASIM dr. Budi Riyanto, DTMH, MSc, SpPD, K-PTI, FINASIM
dr. Arwedi Arwanto, SpPD, K-GH dr. Charles Limantoro, SpPD, K-KV, FINASIM
dr. Hirlan, SpPD, K-GEH, FINASIM Dr. dr. Muchlis Achsan Udji Sofro, SpPD, K-PTI, FINASIM
Dr. dr. K. Heri Nugroho HS, SpPD, K-EMD, FINASIM dr. Bantar Suntoko, SpPD, K-R, FINASIM
dr. Nur Farhanah, MSi.Med, SpPD, K-PTI, FINASIM
EXHIBITION
EVENT AND GATHERING dr. Muhammad Syahrir Azizi, SpPD, K-KV, FINASIM, FICA
dr. Nadia Ayu Mulansari, SpPD, K-HOM, FINASIM dr. Thomas Handoyo, SpPD, K-P
dr. Wismandari, SpPD, K-EMD, FINASIM dr. Nur Alaydrus, SpPD
dr. Mika Lumban Tobing, SpPD, K-HOM, FINASIM
dr. Tania Tedjo Minuljo, SpPD, K-EMD, FINASIM PUBLIC RELATIONS AND PROTOCOLER
dr. Khairunnisa Ayu Kresnanda, SpPD dr. Indra Marki, SpPD, FINASIM
dr. Friska Anggraeni Helena Silitonga, SpPD, K-KV, FINASIM dr. Andreas Arie Setiawan, SpPD, K-KV
dr. Ika Vemilia Warlisti, SpPD
dr. B. Neni Mulyanti, SpPD, FINASIM CONSUMPTION DIVISION
dr. Elizabeth Merry Wintery, SpPD, FINASIM
dr. Farida, SpPD, K-P
dr. Hesti Triwahyu Hutami, SpPD
dr. Cecilia Oktaria Permatadewi, SpPD

PUBLICATION AND DOCUMENTATION

dr. Arif Mansjoer, SpPD, K-KV, FINASIM, M.Epid, KIC
dr. Yosef Purwoko, SpPD, K-Ger, M-Kes.
dr. Ayudyah Nurani, SpPD, K-GH
dr. Setyo Gundi Pramudo, SpPD
dr. Jimmy Tanamas, SpPD

3
 COMMITTEE
DIVISION III CONVOCATION

COMMUNITY SERVICE/DEDICATION HEAD OF FINASIM CONVOCATION

dr. Rejeki Andayani, SpPD, K-Ger Dr. dr. Lugyanti Sukrisman, SpPD, K-HOM, FINASIM
dr. Fathur Nur Kholis, SpPD, K-P MEMBER
dr. Yudo Murti Mupangati, SpPD, K-Ger, FINASIM Dr. dr. Andhika Rachman, SpPD, K-HOM, FINASIM
dr. Dwi Ngestiningsih, SpPD, K-Ger, FINASIM Dr. dr. Rudy Hidayat, SpPD, K-R, FINASIM
dr. Vina Yunarvika, SpPD dr. Ceva Wicaksono Pitoyo, SpPD, K-P, FINASIM, KIC
dr. Simon Salim, SpPD, K-KV, FINASIM, M.Kes, AIFO, FACP, FICA
ARTS & SPORT dr. Ni Made Hustrini, SpPD, K-GH
dr. Zaki Mita Kusumaadhi, SpPD dr. Pujo Hendriyanto, SpPD, FINASIM
dr. Ika Kartiyani, SpPD

TRANSPORTATION & ACCOMMODATION

dr. Suyono, SpPD, K-HOM SECRETARIAT OF PB PAPDI
Oke Fitia
dr. Fenda Adita, SpPD
Dilla Fitria
Husni Amri
LICENSE
dr. Zulfachmi Wahab SpPD, K-HOM Rahmi Safila
dr. Widi Budianto, SpPD Yunus
Supandi
LOGISTICS Riyanto
dr. Bambang Joni Karjono, SpPD, K-Ger, FINASIM Helia Rachma
dr. Agung Prasetyo, SpPD, K-GEH, FINASIM
dr. Ika Syamsul Huda MZ, SpPD SECRETARIAT OF PAPDI SEMARANG CHAPTER
dr. Djoko Agung Priyambodo, SpPD Nindya Berlian
dr. Yanuar Ardani, SpPD Laila Hanifa

4
 GENERAL INFORMATION

TIME & VENUE (VIRTUAL & HYBRID)

LOCATION
Day/Date : July 13 - 17 , 2022
th th PO HOTEL

Venue : PO Hotel- Patra Semarang Hotel &

Convention Semarang

ACCREDITATION BY
Ikatan Dokter Indonesia (IDI)/Indonesian Medical Asosiation

PROGRAM
ORGANIZATIONAL MEETING | WORKSHOP | SYMPOSIUM
CONVOCATION | SCIENTIFIC COMPETITION

INFORMATION & REGISTRATION :

PAPDI SEMARANG CHAPTER CLICK ME

Joanna : 0822 3501 6950

PATRA SEMARANG HOTEL & CONVENTION
Nindy : 0858 8502 5739

OFFICIAL BANK ACCOUNT

Bank : Mandiri Cab. Semarang R.S. Kariadi 13504
Name : KOPAPDI TH 2022
Account No. : 135-00-1818122- 0

CLICK ME

REGISTRATION LINK :

www.kopapdismg22.com

5
 PROGRAM AT GLANCE SEMARANG
LOCATION : PATRA SEMARANG HOTEL & CONVENTION LOCATION : PO HOTEL
SCHEDULE SCHEDULE
TIME Room 1 Room 2 Room 3 Room 4 TIME
Room 5&6 Room 1 Room 2 Room 3 Room 4 Room 5
(Limited Seat) (Limited Seat) (Limited Seat) (Limited Seat)
12.00 - 17.00 PLENO 1 MEETING
Wednesday,

Wednesday,
th

th
17.15 - 19.30 BREAK
July 13

July 13
19.30 - 24.00 COMMISSION MEETING
COMMISSION 1 COMMISSION 2 COMMISSION 3 COMMISSION 4 COMMISSION 5
- MEETING MEETING MEETING MEETING MEETING

08.00 - 11.00 H-WS.1 H-WS.2 H-WS.3 H-WS.4 08.00 - 12.00 COMMISSION MEETING

Poster & Oral

Thursday, July 14th

COMMISSION 1 COMMISSION 2 COMMISSION 3 COMMISSION 4 COMMISSION 5
11.00 - 12.00 BREAK MEETING MEETING MEETING MEETING MEETING
Thursday,
July 14th

12.00 - 15.00 H-WS.5 H-WS.6 H-WS.7 H-WS.8 12.00 - 13.00 BREAK

13.00 - 17.00 PLENO 2 MEETING
17.00 - 19.30 BREAK
19.30 - 21.50 PLENO 2 MEETING

Room 1 Room 2 Room 3 Room 4

07.30 - 08.00 Winner Lecture-1 Winner Lecture-2 Winner Lecture-3 Winner Lecture-4 Winner Lecture-5 07.30 - 08.00 LIVE STREAMING PATRA - WINNER ORAL PRESENTATION
08.00 - 09.00 OPENING 08.00 - 09.00 OPENING SYMPOSIUM
Friday, July 15th

Friday, July 15th

09.00 - 09.30 H-PL.1 H-PL.2 H-PL.3 H-PL.4 - 09.00 - 09.30 V-PL.1 V-PL.2 V-PL.3 V-PL.4
09.30 - 09.45 BREAK 09.30 - 09.45 BREAK
09.45 - 11.45 H-S. 1 H-S.2 H-S.3 H-S.4 - 09.45 - 11.15 V-S.1 V-S.2 V-S.3 V-S.4
11.15 - 12.30 BREAK 11.15 - 12.30 BREAK
12.30 - 14.30 H-LS.1 H-LS.2 H-LS.3 H-LS.4 - 12.30 - 14.30 LUNCH SYMPOSIUM - LIVE STREAMING PATRA
14.30 - 15.00 MEDICAL ETHIC LECTURE 14.30 - 15.00 MEDICAL ETHIC LECTURE - LIVE STREAMING PATRA
15.00 - 15.30 ARTIFICIAL INTELLIGENCE LECTURE 15.00 - 15.30 ARTIFICIAL INTELLIGENCE LECTURE - LIVE STREAMING PATRA
19.00 - 22.00 CONVOCATION CEREMONY
08.00 - 09.30 H-S.5 H-S. 6 H-S.7 H-S.8 - 08.00 - 09.30 V-S.5 V-S.6 V-S.7 V-S.8
Saturday, July 16th

09.30 - 10.00 BREAK 09.30 - 10.00 BREAK

Saturday, July 16th

10.00 - 11.30 H-S.9 H-S.10 H-S.11 H-S.12 - 10.00 - 11.30 V-S.9 V-S.10 V-S.11 V-S.12
11.30 - 12.30 BREAK 11.30 - 12.30 BREAK
12.30 - 14.30 H-LS.5 H-LS.6 H-LS.7 H-LS.8 - 12.30 - 14.30 LIVE STREAMING PATRA - LUNCH SYMPOSIUM
14.30 - 16.00 H-S.13 H-S.14 H-S.15 H-S.16 - 14.30 - 16.00 V-S. 13 V-S.14 V-S.15 V-S.16
16.00 - 18.00 SOCIAL ENTERTAINMENT
18.00 - 22.00 CULTURAL NIGHT

08.00 - 08.30 PAPDI LECTURE PAPDI LECTURE PAPDI LECTURE PAPDI LECTURE 08.00 - 08.30 LIVE STREAMING PATRA
Sunday, July 17th

08.30 - 10.00 H-S.17 H-S.18 H-S.19 H-S.20 - 08.30-10.00 V-S. 17 V-S. 18 V-S. 19 V-S. 20
Sunday,
July 17th

10.00 - 10.30 BREAK 10.00 - 10.30 BREAK

10.30 - 12.30 H-LS.9 H-LS.10 H-LS.11 H-LS.12 - 10.30 - 12.30 LUNCH SYMPOSIUM - LIVE STREAMING PATRA
12.30 - 13.00 CLOSING REMARK 12.30 - 13.00 CLOSING REMARK

H-WS: HYBRID WORKSHOP H-S : HYBRID SYMPOSIUM

H-PL: HYBRID PLENARY LECTURE
V-PL: VIRTUAL PLENARY LECTURE
H-LS: HYBRID LUNCH SYMPOSIUM
V-S: VIRTUAL SYMPOSIUM
6
 SCIENTIFIC PROGRAM
LOCATION : PATRA SEMARANG HOTEL & CONVENTION LOCATION : PO HOTEL
Wednesday, July 13th, 2022 Wednesday, July 13th, 2022
SCHEDULE SCHEDULE
TIME Room 1 Room 2 Room 3 Room 4 TIME
Room 5&6 Room 1 Room 2 Room 3 Room 4 Room 5
(Limited Seat) (Limited Seat) (Limited Seat) (Limited Seat)
- 12.00 - 17.00 PLENO 1 MEETING
17.15 - 19.30 BREAK
19.30 - 24.00 COMMISSION MEETING
COMMISSION 1 COMMISSION 2 COMMISSION 3 COMMISSION 4 COMMISSION 5
MEETING MEETING MEETING MEETING MEETING

7
 SCIENTIFIC PROGRAM
LOCATION : PATRA SEMARANG HOTEL & CONVENTION LOCATION : PO HOTEL
Thursday, July 14 , 2022 Thursday, July 14 , 2022
th th

SCHEDULE SCHEDULE
TIME Room 1 Room 2 Room 3 Room 4 TIME
Room 5&6 Room 1 Room 2 Room 3 Room 4 Room 5
(Limited Seat) (Limited Seat) (Limited Seat) (Limited Seat)
08.00 - 11.00 H-WS.1 H-WS.2 H-WS.3 H-WS.4 08.00 - 12.00 COMMISSION MEETING
Diabetes and It's Related PDL-1: An Unavoidable Maintaining Optimal Incretin-based Therapy.
Multiple Problems Biomarker in Advanced Peritoneal Dialysis
Triple Negative Breast
Cancer

1. The Influence of 1. Applicability of PDL-1 1. Iniatiation of Peritoneal 1. Systemic Effects of

Microbiota on Test to Tailor Triple Dialysis GLP-1 Receptor Agonists
Gastrointestinal Tract in Negative Breast Cancer on Multiple Target Organs.

Poster & Oral

Internal Medicine?

COMMISSION 1 COMMISSION 2 COMMISSION 3 COMMISSION 4 COMMISSION 5

2. Basic Concept of Long- 2. Advancing 2. Prescription on 2. What is The Clinical
MEETING MEETING MEETING MEETING MEETING
acting Insulin Biosimilar in Immunotherapy for Triple Peritoneal Dialysis to Evidence of Once-weekly
Type 2 Diabetes Negative Breast Cancer Achieve Optimal Adequacy GLP-1 Receptor Agonist in
Management. The Treatment of Diabetes
Mellitus?
3. Rational Use of
Antimicrobials in Diabetes 3. Cancer Pain: Relief is 3. Peritoneal Dialysis 3. Recommendations for
with Complications of possible! Complication Starting Long-acting
Sepsis. Incretin Therapy Once a
Week.
Discussion Discussion Discussion Discussion

11.00 - 12.00 BREAK 12.00 - 13.00 BREAK

13.00 - 16.00 H-WS.5 H-WS.6 H-WS.7 H-WS.8 13.00 - 17.00
HIV AIDS Treatment and Core Elements in Knee Osteoarthritis From Basic to Advanced
Challenge Anticoagulation Therapy Management Endoscopy Workshop
Moderator

1. Implementation and 1. What to Look for in 1. Current Treatment 1. Basic Gastro-

Access to Pre-Exposure Venous Trombo Embolism Modalities of Knee Colonoscopy: Tips and
Poster & Oral

Prophylaxis: How and Atrial Fibrillation Osteoarthritis Tricks

Effective? Thromboembolism?
PLENO 2 MEETING
2. Access to Tuberculosis 2. Atrial Fibrillation : 2. Hyaluronic Injection for 2. Endoscopic Nutritional
Prevention Treatment for Common Pitfalls and Knee Osteoarthritis Access
People Live With HIV Strategies

3. Immune Reconstitution 3. Venous 3. Knee Intraarticular 3. Endoscopic Hemostasis

Inflammatory Syndrome: Thromboembolism : Injection: Indication and Therapy
Emergencies Related to Common Pitfalls and Techniques
HIV Infection Strategies
17.00 - 19.30 BREAK
Discussion Discussion Discussion Discussion
19.30 - 21.50 PLENO 2 MEETING

8
 SCIENTIFIC PROGRAM
LOCATION : PATRA SEMARANG HOTEL & CONVENTION LOCATION : PO HOTEL
Friday, July 15th, 2022 Friday, July 15 , 2022
th

SCHEDULE SCHEDULE
TIME Room 1 Room 2 Room 3 Room 4 TIME
Room 5&6 Room 1 Room 2 Room 3 Room 4
(Limited Seat) (Limited Seat) (Limited Seat) (Limited Seat)
07.30 - 08.00 Winner Lecture-1 Winner Lecture-2 Winner Lecture-3 Winner Lecture-4 Winner Lecture-5 07.30 - 08.00 LIVE STREAMING PATRA - Winner Oral Presentation
08.00 - 09.00 OPENING SYMPOSIUM 08.00 - 09.00 OPENING SYMPOSIUM

09.00 - 09.30 H-PL.1 H-PL.2 H-PL.3 H-PL.4 09.00 - 09.30 V-PL.1 V-PL.2 V-PL.3 V-PL.4
Advanced Diabetes Advanced Breast Cancer Systemic Lupus Heart Failure Artificial Intelligence in Interventional Pulmonology: Challenge in Infectious Artificial Intelligence in
Therapy Erythematous Nephrology A New World Disease in The Next Decade Gastroenterohepatology

Discovery of Once weekly Increasing Patient Infection in Systemic Update Management on Impact of Artificial Intelligence Advancing of Pulmonolgy Global Warming and Infectious Artificial Intelllegence in
GLP-1 reseptor agonist Outcome with Palbociclib Lupus Erythematosus, Heart Failure - and Big data on Chronic Kidney Intervention in Diagnosis of Disease: Lesson Learn from Endoscopy Field: Present and
for HR+/HER2 Advance Similarities, and Disease Management Early Lung Cancer COVID-19 Pandemic Future
Breast Cancer Differences with Lupus
Flare

09.30 - 09.45 BREAK 09.30 - 09.45 BREAK

09.45 - 11.15 H-S.1 H-S.2 H-S.3 H-S.4 09.45 - 11.15 V-S.1 V-S.2 V-S.3 V-S.4
Hypertension and Chronic Save Patients, Save Lives: Sarcopenia and Insulin Co-formulation New Breakthrough in HCC Polypharmacy in Geriatric Chronic Hepatitis: From Hypertension to Heart
Kidney Disease Related Focus on Managing Dyslipidemia Update and Its Complication Diagnosis and Management Failure
Complications Severe Infections in Update
Hospital
1. Screening and Early 1. Defining Polypharmacy in 1. New Diagnostic Tool of Liver 1. Evolution of Hypertension
1. Fixed Combination Anti- 1. Navigating the MDR 1. Update Management 1. Appropriate Clinical Detection of Hepatocellular The Elderly: When to Fibrosis form Primary to Management : The Increasing
Hypertensive Drugs and Gram Negative & DTR Dyslipidemia, on HDL As Conditions Using Insulin - Carcinoma: New Evidences Rationalize Medications? Advanced Role of Single Pill Combination
Outcomes Pseudomonas Infections Cardiovascular Frisk in The Co-formulation as Insulin Therapy for Powerful Blood
Treatment Paradigm Elderly Patients Initiation Therapy. Pressure Control

2. Upper GI bleeding in 2. The Emergence of Life- 2. Managing Sarcopenia 2. How to Determine 2. Improving Outcome for HCC 2. Refractory GERD in Patient 2. Anti Viral Therapy for CHB: 2. Challenges in Hypertensive
CKD: Challenge and threatening Invasive Mold with Hydroxy Methyl Insulin Co-formulation as Using Systemic Therapy with Polypharmacy Can We Stop Before HBsAg Patients with Coronary Artery
Management Infections in Febrile Butarat : Clinical Evidence Insulin Intensive Therapy Loss? Disease : Time to Act Towards
Neutropenia: Who, When, on Strength and Recovery a Better Patient Care
and How?
Discussion Discussion Discussion Discussion Discussion Discussion Discussion Discussion

11.15 - 12.30 BREAK 11.15 - 12.30 BREAK

9
 SCIENTIFIC PROGRAM
LOCATION : PATRA SEMARANG HOTEL & CONVENTION LOCATION : PO HOTEL
Friday, July 15th, 2022 Friday, July 15 , 2022
th

SCHEDULE SCHEDULE
TIME Room 1 Room 2 Room 3 Room 4 TIME
Room 1 Room 2 Room 3 Room 4
(Limited Seat) (Limited Seat) (Limited Seat) (Limited Seat)
12.30 - 14.30 H-LS.2 H-LS.3 H-LS.4 12.30 - 14.30
H-LS.1
Comprehensive Management Novel Clinical Perspectives on Development and Application COVID-19: From Bench to
for Cancer Patients from Injectable GLP-1 RA Pharmacogenomic in Bedside
Therapy to Prevention Indonesia
Secondary Infections

1. Strategies to Increase Cure 1. Time In Range (TIR) in 1. Cancer Risk and 1. Immunology of COVID-19:
Rates for Advanced EGFR+ Clinical Practice: What is The Pharmacogenic Current State and Future
NSCLC Wisdom of Research Direction

2. Invasive and Complicated 2. How to Control Fasting and 2. Genome Wide Association 2. Clinical Management of
Pneumococcal Infection in Prandial Hyperglycemia Study in Rheumatic Diseases : COVID-19 Pneumonia LUNCH SYMPOSIUM - LIVE STREAMING PATRA
Oncology Patients Flexibly & Effectively Approach to Establishing
Mechanism and Function for
Genetic Association

3. Role of Pneumococcal 3. Importance and Safe 3. Precision Medicine and 3. The Role of Anti
Vaccination in Oncology Benefits of Using The FRC Genetic Testing for Improved Inflammation in Management
Patients: What the Guideline (Fixed Ratio Combination) Treatment of Gastrointestinal COVID-19
Says? Methods Disease

Discussion Discussion Discussion Discussion

14.30 - 15.00 MEDICAL ETHIC LECTURE 14.30 - 15.00 MEDICAL ETHIC LECTURE - LIVE STREAMING PATRA
15.00 - 15.30 ARTIFICIAL INTELLIGENCE LECTURE 15.00 - 15.30 ARTIFICIAL INTELLIGENCE LECTURE - LIVE STREAMING PATRA
19.00 - 22.00 CONVOCATION CEREMONY

10
 SCIENTIFIC PROGRAM
LOCATION : PATRA SEMARANG HOTEL & CONVENTION LOCATION : PO HOTEL
Saturday, July 16th, 2022 Saturday, July 16th, 2022
SCHEDULE SCHEDULE
TIME Room 1 Room 2 Room 3 Room 4 TIME
Room 1 Room 2 Room 3 Room 4
(Limited Seat) (Limited Seat) (Limited Seat) (Limited Seat)
08.00 - 09.30 H-S.5 H-S.6 H-S.7 H-S.8 08.00 - 09.30 V-S.5 V-S.6 V-S.7 V-S.8
The Role of Rapid Acting Cardiovascular Protection Anemia on Chronic Kidney Gastrointestinal Cancer Cardiovascular Disease and Hepatology in Daily Practice: Beta Blockers in Daily Lower Gastro Intestinal Tract
Insulin Analog Disease Management Landscape Gastrointestinal Bleeding Hot News Practice Problem in Elderly
Event
1. When to Choose Basal Plus 1. Synergistic Dual Fixed Dose 1. Etiology of Anemia on 1. Diagnosis in GI Cancer 1. STEMI and Antiplatelet - 1. New Trend of Non Invasive 1. Non-Cirrhosis Portal 1. Chronic Constipation in
or Basal Bolus Combination for Chronic Kidney Disease (Gastric and Colorectal Cancer) Right Reperfusion and Diagnostic Tool of Liver Hypertension: The Emerging Elderly
Cardiovascular Protection Treatment : Improved Cirrhosis Disease
Outcome Matter
2. Hyperglycemia In-Patient 2. When to Consider Potent 2. Hemoglobin Variability in 2. Breakthrough Treatment in
with Comorbidities Reversible P2Y12 Inhibitor in Anemia of Chronic Kidney GI Cancer 2. Gastrointestinal Protection 2. Optimizing Management of 2. Beta Blocker in Heart Failure 2. Optimizing Colonoscopy
ACS Patients Disease in Cardiovascular Disease Portal Hypertension: Focus on Quality : From Preparation to
Gastric and Varices Gaster Surveillance of Colorectal
Discussion Discussion Discussion Discussion Bleeding Cancer

Discussion Discussion Discussion Discussion

09.30 - 10.00 BREAK 09.30 - 10.00 BREAK

10.00 - 11.30 H-S.9 H-S.10 H-S.11 H-S.12 V-S.12
10.00 - 11.30 V-S.9 V-S.10 V-S.11
Evolution of Haemophilia Pain Control and Uric Gastrointestinal Disorders in The Big Picture of Systemic Lupus Hot Topics in Cardio- A New Hope for Heart Failure Infectious and Non-infectious
Care, Whre Are We Now? Lowering Therapy Elderly Hypertension and Erythematosus & Lupus Hepatology Disorders Lower Gastro Intestinal
Dyslipidemia : Looking for Nephritis : Current Guidelines Problems
Optimal Patient Outcome
1. Systemic Lupus 1. New Emerging Therapies in 1. The Journey From 1. Infectious Disease of The
1. The Changing World of 1. Optimizing Pain 1. Alteration of Gut 1. Closing The Gaps in Current Erythematosus : Whats New? Liver Cirrhosis Hypertension to Heart Failure : Lower GI Tract : Focus on
Bleeding Disorder Management in Gout Arthritis Microbiome in Elderly and The Lipid Management Pathophysiology and Its Clostridium Difficile
Consequences Updated Treatment

2. Translating Evidence into 2. Switching Allopurinol to 2. Peptic Ulcer in Patients with 2. Overcoming Challenge in 2. Lupus Nephritis 2. Cardiac Cirrhosis : Whats 2. Do We Need Single Pill 2. Inflammatory Bowel
Daily Clinical Practice : Safety, Febuxostat in Gout Treatment: Comorbidities Hypertension Management : A Management New? Combination of Oral Anti Disease : Asian Perspectives
Relialibity, and Portability of The Efficacy and Safety Look at Vasodilator Beta- Recommendation from KDIGO Hypertension in Management
Turoctocog Alfa Blocker Guideline 2021 Arteriosclerosis?

Discussion Discussion Discussion Discussion Discussion Discussion Discussion Discussion

11.30 - 12.30 BREAK 11.30 - 12.30 BREAK

11
 SCIENTIFIC PROGRAM
LOCATION : PATRA SEMARANG HOTEL & CONVENTION LOCATION : PO HOTEL
Saturday, July 16th, 2022 Saturday, July 16th, 2022
SCHEDULE SCHEDULE
TIME Room 1 Room 2 Room 3 Room 4 TIME
Room 1 Room 2 Room 3 Room 4
(Limited Seat) (Limited Seat) (Limited Seat) (Limited Seat)
12.30 - 14.30 H-LS.5 H-LS.6 H-LS.7 H-LS.8 12.30 - 14.30
Expanding Precision A New Class Drug for Heart Unmeet Beyond PPI in Acid Insulin and Antioxidant
Medicine-Increasing Patient Failure and Diabetic Patients Related Disorders
Care Value

1. Integrated Digital 1. SGLT-2 Inhibitor, A New 1. Novel Therapy for GERD: 1. Biosimilar Insulin Also
Application for Doctors to Multi Organ Approach Beyond Proton Pump Inhibitor Contributes Equally to DM
Achieve High-Care Value Theraphy in Chronic Heart Type 2 Management
Failure
LIVE STREAMING PATRA - LUNCH SYMPOSIUM
2. Intestinal Homeostasis as 2. Reno-Protective Effect of 2. Personalized Approach in 2. The Effect of Vitamin D
New Target in Disease SGLT-2 Inhibitor: Evidence Management of H. Pylori Supplementation on Metabolic
Prevention and Therapy Based Research Infection Disorders of The Body

3. Paradigm Shift Into 3. What are The Multiple 3. Basic Immune Response in 3. Which One The Best of
Genomics Testing Oriented Metabolic Benefits of Using Autoimmune Diseases and Antioxidant Activity on
Patient Management SGLT2-Inhibitors in High-Risk Role of Anti-Oxidant Natural Course of Diabetes?
Populations?
Discussion Discussion Discussion Discussion

14.30 - 16.00 H-S.13 H-S.14 H-S.15 H-S.16 14.30 - 16.00 V-S. 13 V-S.14 V-S.15 V-S.16
Prevention of Venous The Role of Artificial Hypertension in Endocrine Comprehensive Geriatric All About Axial Update In The Management Prevention of Chronic Kidney Gout and NSAIDs Update
Thromboembolism in Intelligence in Pulmonary Disorder Approach in Frailty Patient Spondyloarthritis of Inflammatory Bowel Disease-Mineral Bone
Medically Ill Patients: A Medicine Disease Disorder
Clinical Update

1. The State of Art and Science 1. Artificial Intelligence in 1. How to Screen 1. Palliative Care in Geriatric: 1. Opportunity and Challenge 1. Inflammatory Bowel 1. Pathogenesis of Mineral 1. Chronic NSAID in Rheumatic
in Prevention of VTE in Respiratory Medicine: Hypertension on Endocrine Failure to Thrive in The Diagnosis of Low Back Disease in Clinical Practice Bone Disorder in Chronic Disease : Pro and Contra
Medically Ill Patients Approach to Personalized Disorder Pain from Primary to Tertiary Care : Kidney Disease
Treatment Diagnosis and Assesment

2. New Insights Into The 2. Early Detection of ARDS in 2. Hypertensive Crisis: How to 2. Holistic Management in 2. The Role of Anti Interleukin 2. The Role of Biologic Agent 2. New Agent for controlling 2. Gout Arthritis Prophylaxis
Mechanisms of VTE in COVID -19: Role of Artificial Prevent Target Organ Damage Elderly Failure to Thrive: 17 in Axial Spondyloarthritis in Inflammatory Bowel Hyperphosphatemia in Chronic Treatment: The Gold Standard
Medically Ill Patients Intelligence in Lung Vessel Focused in Psychosomatic Disease Disease Highlighting The Kidney Disease Therapy
Volume Unmeet Need

Discussion Discussion Discussion Discussion Discussion Discussion Discussion Discussion

16.00 - 18.00 SOCIAL ENTERTAINMENT

18.00 - 22.00 CULTURAL NIGHT

12
 SCIENTIFIC PROGRAM
LOCATION : PATRA SEMARANG HOTEL & CONVENTION LOCATION : PO HOTEL
Sunday, July 17th, 2022 Sunday, July 17th, 2022
SCHEDULE SCHEDULE
TIME Room 1 Room 2 Room 3 Room 4 TIME
Room 1 Room 2 Room 3 Room 4
(Limited Seat) (Limited Seat) (Limited Seat) (Limited Seat)
08.00 - 08.30 PAPDI LECTURE 1 PAPDI LECTURE 2 PAPDI LECTURE 3 PAPDI LECTURE 4 08.00 - 08.30 LIVE STREAMING PATRA
08.30 - 10.00 H-S.17 H-S.18 H-S.19 H-S.20 V-S. 17 V-S. 18 V-S. 19 V-S. 20
08.30 - 10.00
Tuberculosis Management: Electrolyte Imbalance Rational Choice of Drugs in Hepatology and Cardiology Nutraceutical in Internal Vaccination in Adult New Approach in Diagnostic Common Gastro-Hepatology
The Challenge Prediabetic and Diabetic Cases in Daily Practice Medicine : New Evidences Testic of Infectious Disease Cases in Daily Practice

1. Tuberculosis Management: 1. Renal and Sodium 1. Wise Attitude on How to 1. Management of Hepatitis C 1. Oral Protein-Based 1. Vaccination In Special 1. Syndromic Diagnostic 1. Best Approaches and
Old and New Disturbance Choose Insulin Anti-resistance in Indonesia : from Guideline Nutritional Supplementary in Condition: What We Have to Testing: A New Approach to Management of
Drugs in Prediabetic to Practice Critically Ill Know? Management of Patients with Choledocholithiasis
Infectious Diseases

2. Drug Induced Liver Injury in 2. Hyponatremia in Liver 2. Optimizing Glycemic Control 2. The Role of P2Y12 Inhibitor 2. The Role of Oral Albumin in 2. Booster Covid-19 2. Causative Organisms of 2. How to Choose Antibiotics
Anti Tuberculosis Drugs Cirrhosis with Fixed Dose Combination in CAD Pulmonary Diseases Vaccination: When and How Severe Pneumonia in The ICU in Intra-Abdominal Infections
We Choose it? (During Pandemic) in
Indonesia Hospitals.

Discussion Discussion Discussion Discussion Discussion Discussion Discussion Discussion

10.00 - 12.30 H-LS.9 H-LS.10 H-LS.11 H-LS. 12 10.00 - 10.30 BREAK
Hepato-Cardio-Metabolic Comprehensive Approach Improve Better Outcome of Critical Ill in Internal Medicine 10.30 - 12.30
Axis: New Paradigm and Management of Hemodialysis
Functional Gastrointestinal
Disease

1. MAFLD: Guideline from 1. Novel Therapy in Functional 1. Maintaining Volume 1. Central Line Associated
Primary to Advanced Setting Dyspepsia Overload in Hemodialysis Bloodstream Infection:
Management Challenging in Diagnosis and
Treatment
2. Metabolic Syndrome and 2. Current and Future 2. Intradialysis Hypertension:
Diabetes Management in Treatment of IBS How to Maintain Optimal 2. Comprehensive LIVE STREAMING PATRA - LUNCH SYMPOSIUM
MAFLD Blood Pressure Management of ARDS: Focus
on Protective Lung Strategy

3. Cardiovascular Risk 3. Psychological Comorbidities 3. Prevention of 3. Cardiogenic Shock in

Protection and Management in FGID : How to Manage? Cardiovascular Risk in Patients with Acute Coronary
in MAFLD Hemodialysis Syndrome

Discussion Discussion Discussion Discussion

12.30 - 13.00 CLOSING REMARK 12.30 - 13.00 CLOSING REMAKE

13
 REGISTRATION

A. HYBRID SYMPOSIUM + HYBRID WORKSHOP

Early Bird Late Bird

NO REGISTRATION
(Before June 2022) (After June 2022)
1. Spesialist/Consultant Non FINASIM Rp 5.000.000, - Rp 5.500.000, -
2. Spesialist/Consultant FINASIM Rp 4.500.000, - Rp 5.000.000, -
3. GP/Resident/Internship Rp. 3.000.000, - Rp. 3.500.000, -
4. Student/Clerckship Rp. 1.500.000, - Rp. 2.500.000, -

B. HYBRID SYMPOSIUM

Early Bird Late Bird

NO REGISTRATION
(Before June 2022) (After June 2022)
1. Spesialist/Consultant Non FINASIM Rp 4.500.000, - Rp 5.000.000, -
2. Spesialist/Consultant FINASIM Rp 4.000.000, - Rp 4.500.000, -
3. GP/Resident/Internship Rp 2.500.000, - Rp. 3.000.000, -
4. Student/Clerckship Rp. 1.000.000,- Rp. 1.500.000, -

C. VIRTUAL SYMPOSIUM + VIRTUAL WORKSHOP

Early Bird Late Bird

NO REGISTRATION
(Before June 2022) (After June 2022)
1. Spesialist/Consultant Non FINASIM Rp 2.000.000, - Rp 2.500.000, -
2. Spesialist/Consultant FINASIM Rp 1.500.000, - Rp 2.000.000, -
3. GP/Resident/Internship Rp 1.000.000, - Rp. 1.500.000, -
4. Student/Clerckship Rp. 500.000,- Rp. 1.000.000, -

BANK ACCOUNT
Contact Person :
Bank: Mandiri Cab. Semarang R.S. Kariadi 13504
Name: KOPAPDI TH 2022 Joanna : 082235016950
Nindy : 085885025739
Account Number: 135-00-1818122- 0

14
 FREE PAPER
Abstract Submission Guideline General Terms Of Writing
1) Registered as a participants of KOPAPDI XVIII 1) Manuscripts are typed using standard
2022 Semarang Indonesian according to EYD
2) The deadline for submitting the last paper is 2) The manuscript is typed on A4 paper with 1.5
May 31 , 2022 spacing between lines and uses the type and
st

3) Papers are received by the committee in size of the font "Times New Roman 12', except
softcopy, sent to email for the abstract which is typed in one space.
[email protected] 3) Abstract, written on one page apart, maximum
4) We will reply to the papers we have received, 500 words, excluding the title and name of the
and we will give serial numbers for papers that researcher. Compiled based on Introduction,
have passed the selection Methods, Results, Discussion (IMRAD).
5) All contestants' works remain the property and 4) Typing limit: left side 4 cm; right 3 cm; upper
copyright of the contestants. limit 3 cm; lower limit 3 cm,
6) Writing and posters must be free from 5) The title of the image is placed below the image,
plagiarism (must be original). with a font size of 10, bold.
7) It is forbidden to use materials that have 6) The title of the table is placed above the table,
Intellectual Property Rights (IPR) with font size 10, bold. The table uses only a
8) Matters related to conditions that are not horizontal border without a vertical border. The
detailed will be arranged later and delivered via head of the table uses capital letters, with size
email. 10, bold. The body of the table uses a font size
9) The decision of the jury is final and cannot be of 10.
contested. 7) Bibliography uses the Vancouver system.

Terms and conditions are subject to change without prior notice. For More information visit our website.
https://kopapdismg22.com/

15
SECRETARIAT OF PAPDI SEMARANG CHAPTER CONTACT:
Jl. Dr. Sutomo, No 16 Semarang PAPDI SEMARANG CHAPTER
Telp. Fax : (024) 8446758 Joanna: 0822 3501 6950
Email: [email protected] Nindy: 0858 8502 5739
Web: www.kopapdismg22.com

kopapdisemarang kopapdisemarang kopapdi semarang KOPAPDI SEMARANG KOPAPDI SEMARANG 2022